Lung Transplantation under a Janus Kinase Inhibitor in Three Patients with SAVI Syndrome

Lung Inflammation in STING-Associated Vasculopathy with Onset in Infancy (SAVI)

(2022) Clémence David et al.   Cells

Adverse events associated with JAK inhibitors in 126,815 reports from the WHO pharmacovigilance database

(2022) Léa Hoisnard et al.   Scientific Reports

A 17-Year-Old Girl Diagnosed With STING-Associated Vasculopathy With Onset in Infancy (SAVI) After Lung Transplantation

(2022) Dohyung Kim et al.   CHEST

Severe Liver Disorder Following Liver Transplantation in STING-Associated Vasculopathy with Onset in Infancy

(2021) Takashi Ishikawa et al.   JOURNAL OF CLINICAL IMMUNOLOGY

STING-Mediated Lung Inflammation and Beyond

(2021) Marie-Louise Frémond et al.   JOURNAL OF CLINICAL IMMUNOLOGY

Type 1 interferonopathy presenting as juvenile idiopathic arthritis with interstitial lung disease: report of a new phenotype

(2020) S. L. N. Clarke et al.   Pediatric Rheumatology

Overview of STING-Associated Vasculopathy with Onset in Infancy (SAVI) Among 21 Patients

(2020) Marie-Louise Frémond et al.   Journal of Allergy and Clinical Immunology-In Practice

Évolution et progrès en transplantation pulmonaire : étude de la cohorte de 600 premiers patients transplantés pulmonaires à l’hôpital Foch

(2019) A. Roux et al.   REVUE DES MALADIES RESPIRATOIRES

STING-associated lung disease in mice relies on T cells but not type I interferon

(2019) Hella Luksch et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Efficacy and Adverse Events During Janus Kinase Inhibitor Treatment of SAVI Syndrome

(2019) Stefano Volpi et al.   JOURNAL OF CLINICAL IMMUNOLOGY

Hierarchy of clinical manifestations in SAVI N153S and V154M mouse models

(2019) Mona Motwani et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

JAK1/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies

(2018) Gina A. Montealegre Sanchez et al.   JOURNAL OF CLINICAL INVESTIGATION

Development of a Validated Interferon Score Using NanoString Technology

(2018) Hanna Kim et al.   JOURNAL OF INTERFERON AND CYTOKINE RESEARCH

Severe Pulmonary Fibrosis as the First Manifestation of Interferonopathy (TMEM173 Mutation)

(2016) Cécile Picard et al.   CHEST

Efficacy of the Janus kinase 1/2 inhibitor ruxolitinib in the treatment of vasculopathy associated with TMEM173 -activating mutations in 3 children

(2016) Marie-Louise Frémond et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Copa Syndrome: a Novel Autosomal Dominant Immune Dysregulatory Disease

(2016) Timothy J. Vece et al.   JOURNAL OF CLINICAL IMMUNOLOGY

Activated STING in a Vascular and Pulmonary Syndrome

(2014) Yin Liu et al.   NEW ENGLAND JOURNAL OF MEDICINE